PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15322503-11	2004	Multivariate analysis disclosed that urinary beta-2-microglobulin was independently correlated with the urinary concentrations of pentosidine and pyrraline (P <.05 for both).	pentosidine	130-141	beta-2-microglobulin	Homo sapiens	45-65	
15980621-6	2005	RESULTS: The switch from conventional to ultrapure dialysate significantly decreased plasma levels of beta2MG, from 30.1 +/- 1.4 to 27.1 +/- 1.4 mg/dl (p < 0.05) and pentosidine, from 1,535.8 +/- 107.5 to 1,267.6 +/- 102.9 nmol/l (p < 0.01) after 1 month of use.	pentosidine	169-180	beta-2-microglobulin	Homo sapiens	102-109	
8941621-0	1996	Elevated pentosidine content in amyloid deposits and in insoluble amyloid fibrils from patients with beta 2-microglobulin amyloidosis.	pentosidine	9-20	beta-2-microglobulin	Homo sapiens	101-121	
12021521-8	2002	The plasma pentosidine level in patients with renal disease correlated significantly with plasma creatinine, urea nitrogen, beta2-microglobulin, and creatinine clearance, indicating its usefulness in evaluating the severity of renal disease.	pentosidine	11-22	beta-2-microglobulin	Homo sapiens	124-143	
11264780-3	2001	beta(2)-microglobulin (beta(2)M) amyloid was demonstrated to be modified with advanced glycation end products (AGEs) such as imidazolone, N(epsilon)-(carboxymethyl)lysine (CML), and pentosidine.	pentosidine	182-193	beta-2-microglobulin	Homo sapiens	0-21	
11264780-3	2001	beta(2)-microglobulin (beta(2)M) amyloid was demonstrated to be modified with advanced glycation end products (AGEs) such as imidazolone, N(epsilon)-(carboxymethyl)lysine (CML), and pentosidine.	pentosidine	182-193	beta-2-microglobulin	Homo sapiens	23-31	
9782569-11	1998	Of potential clinical importance are pentosidine-, imidazolone- and carboxymethyllysine-modifications of beta 2-microglobulin with respect to the development of uraemia associated amyloidosis.	pentosidine	37-48	beta-2-microglobulin	Homo sapiens	105-125	
8637877-0	1996	Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.	pentosidine	18-29	beta-2-microglobulin	Homo sapiens	91-111	
8637877-4	1996	Determination by both HPLC assay and competitive ELISA demonstrated a significant amount of pentosidine in amyloid-fibril beta-2m from long-term hemodialysis patients with DRA, and the acidic isoform of beta-2m in the serum and urine of hemodialysis patients.	pentosidine	92-103	beta-2-microglobulin	Homo sapiens	122-129	
7569788-8	1995	In addition, there was a significant correlation between plasma levels of pentosidine and beta 2-microglobulin before hemodialysis in 116 uremic patients.	pentosidine	74-85	beta-2-microglobulin	Homo sapiens	90-110